Treatment of drug-induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intensive-care unit;Behandlung einer medikamenten-induzierten Agranulozytose mit Granulozyten-Colony Stimulating Factor (G-CSF) auf einer operativen Intensivstation
Successful treatment of carbimazole-induced agranulocytosis and severe sepsis with granulocyte macrophage colony stimulating factor
Freebairn RC, Young RJ, Gomersall CD, Wickham NWR, Critchley JAJH. Successful treatment of carbimazole-induced agranulocytosis and severe sepsis with granulocyte macrophage colony stimulating factor. Anaesth. Intens. Care 1995;23:510-512
Drug-induced agranulocytosis: Evidence for the commitment of bone marrow haematopoesis
Heit W, Heimpel H, Fischer A, Frickhofen N: Drug-induced agranulocytosis: Evidence for the commitment of bone marrow haematopoesis. Scand. J. Haematol. 1985;35:459-468
Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis
Nand S, Bayer R, Prinz R, Felten W, Godwin J: Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis. Am. J. Hematol. 1991;37:267-269
Risks of agranulocytosis and aplastic anemia - A first report of their relation to drug use with special reference to analgetics
The international agranulocytosis and aplastic anemia study: Risks of agranulocytosis and aplastic anemia - a first report of their relation to drug use with special reference to analgetics. J Am. Med. Assoc. 1986;256:1749-1757
Rapid neutrophil recovery from acquired agranulocytosis-by recombinant human granulocyte-macrophage colony stimulating factor in an intensive care patient
Weiss M, Gross-Weege W, Wernet P: Rapid neutrophil recovery from acquired agranulocytosis-by recombinant human granulocyte-macrophage colony stimulating factor in an intensive care patient. Crit. Care. Med. 1992;20:1490-1491